Squamous cell carcinoma of vulva/vagina research hub

PEVOsq: Phase II basket trial evaluating the efficacy of a combination of pembrolizumab and vorinostat in patients with recurrent and/or metastatic squamous cell carcinoma

This study looks at a new combination treatment for certain skin cancers that have returned or spread. It uses a specific drug to see how many patients respond positively to the treatment.